19-45872721-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004497.3(FOXA3):c.716C>T(p.Ser239Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,603,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004497.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXA3 | NM_004497.3 | c.716C>T | p.Ser239Leu | missense_variant | 2/2 | ENST00000302177.3 | NP_004488.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXA3 | ENST00000302177.3 | c.716C>T | p.Ser239Leu | missense_variant | 2/2 | 1 | NM_004497.3 | ENSP00000304004.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152006Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000225 AC: 5AN: 221906Hom.: 0 AF XY: 0.0000246 AC XY: 3AN XY: 122156
GnomAD4 exome AF: 0.000187 AC: 271AN: 1451474Hom.: 0 Cov.: 32 AF XY: 0.000182 AC XY: 131AN XY: 721478
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152006Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | The c.716C>T (p.S239L) alteration is located in exon 2 (coding exon 2) of the FOXA3 gene. This alteration results from a C to T substitution at nucleotide position 716, causing the serine (S) at amino acid position 239 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at